A recent study in adults with IBD demonstrated that fMPO was an accurate marker of gut inflammation when compared to ileocolonoscopy and performed comparably to fCal.17 Fecal MPO levels were able to predict moderate-to-severe disease activity, declined following initiation of biologic therapies, and could predict a more complicated disease course. This evidence concerns the gene MPO and inflammatory bowel disease.